Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Postmarket Drug Safety Surveillance: Updates On Sentinel, OMOP Projects

Executive Summary

FDA is making progress on creating a common language that would allow for drug safety queries in disparate database sources linked to a national Sentinel network, according to FDA Office of the Commissioner Senior Policy Analyst Melissa Robb
Advertisement

Related Content

Sentinel Initiative's Potential Shortcomings Illuminated At Avandia Panel
Sentinel Initiative's Potential Shortcomings Illuminated At Avandia Panel
"Mini Sentinel" With Harvard Gets FDA Halfway To Health Record Target
"Mini Sentinel" With Harvard Gets FDA Halfway To Health Record Target

Topics

Advertisement
UsernamePublicRestriction

Register

PS052403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel